New Prix Galien Canada Jury members 2015

Dr.Kishor M. Wasan

We are pleased to announce that Dr.Kishor M. Wasan has joined the Jury of Prix Galien Canada. Dr. Wasan is Professor and Dean at the College of Pharmacy and Nutrition at the University of Saskatchewan. He is also Adjunct Professor and Distinguished University Scholar at UBC Faculty of Pharmaceutical Sciences and Former Director of the Neglected Global Diseases Initiative at UBC.

Dr. Helen Burt

Dr Burt has been serving as the Associate Vice President Research & International in the Office of the Vice President Research & International at the University of British Columbia since 2011 and is the Angiotech Professor of Drug Delivery in the Faculty of Pharmaceutical Sciences at UBC. She was born in Manchester, England and obtained her B. Pharm. (Hons) from the University of Bath and her Ph.D in Pharmaceutics from UBC. Her major research efforts are supported by grants from CIHR and NSERC and involve the development of polymer-based drug delivery systems, in particular micro- and nanoparticulates, for controlled and localized drug delivery. She has published over 150 peer-reviewed papers and 8 patents. She has been the recipient of several teaching prizes and research awards, including the UBC Killam Teaching Prize and Killam Faculty Research Prize, NSERC Synergy Award for Innovation, CSPS Award of Leadership in Canadian Pharmaceutical Sciences and YWCA Woman of Distinction Award for Science, Research and Technology. She is a founding scientist in the Centre for Drug Research and Development (CDRD), a member of the Canadian Academy of Health Sciences and has served on the Board of Directors of the Provincial Health Services Authority.

Dr. Mark a. Wainberg

Dr. Mark A. Wainberg is Professor of Medicine and Microbiology and Immunology at McGill University in Montreal, where he also serves as Director of the McGill University AIDS Centre. Dr. Wainberg is an internationally recognized scientist in the field of HIV/AIDS. He served as President of the International AIDS Society between 1998 and 2000.  He is well-known for his initial identification of 3TC as an anti-viral drug, in collaboration with BioChem Pharma Inc, in 1989, as well as for multiple contributions to the field of HIV drug resistance. Dr. Wainberg now works on efforts to achieve a cure for HIV infection. Dr. Wainberg is an elected fellow of the Royal Society of Canada and he is an Officer of the Order of Canada.  He is also an Officer of the Ordre National du Québec, a Chevalier in the Legion d’Honneur of France, an Honorary Fellow of the Royal College of Physicians and Surgeons of Canada, the recipient of the Killam Prize in Health Sciences for 2012, and the recipient of the Cubist-ICAAC Award of the American Society for Microbiology for outstanding achievement in research on infectious diseases, for 2014.

Dr. Serge Gauthier

Medical studies at Université de Montréal, Neurology training at McGill University, Research Fellowship at Prof. Theodore L. Sourkes laboratory, Allen Memorial Institute, Montreal. Clinical investigator and staff neurologist at the Montreal Neurological Hospital and Institute (1976-1986), Director of the McGill Centre for Studies in Aging (1986-1996), Senior Scientist of the CIHR-Rx&D program (1997-2007). Currently Professor in the Departments of Neurology & Neurosurgery, Psychiatry, Medicine, at McGill University, and Director of the Alzheimer Disease and Related Disorders Research Unit of the McGill Center for Studies in Aging, Douglas Hospital. Contributions to research include design and implementation of randomized clinical trials in order to establish the safety and efficacy of cholinesterase inhibitors, muscarinic agonists, and agents possibly modifying progression for Alzheimer’s disease and vascular dementia. Special interests include consensus approach to the management of dementia in different stages, the ethics of research involving persons with dementia, and primary prevention strategies against cognitive decline and dementia.